Technical Analysis for BCT - Briacell Therapeutics Corp.

Grade Last Price % Change Price Change
F 0.850 6.25% 0.050
BCT closed up 6.25 percent on Wednesday, November 20, 2024, on 18 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Dec 12
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 6.25%
Narrow Range Bar Range Contraction 6.25%
Wide Bands Range Expansion 6.25%
Down 3 Days in a Row Weakness 6.25%
Oversold Stochastic Weakness 6.25%
Narrow Range Bar Range Contraction 3.66%
Wide Bands Range Expansion 3.66%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Briacell Therapeutics Corp. Description

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company. The Company is engaged in the research and development of cancer immunotherapy technology. The Company offers BriaVax, an immunotherapy vaccine. The Company is engaged in developing and advancing its BriaVax immunotherapy vaccine for patients with advanced breast cancer. The Company is also engaged in the research and development of its companion diagnostic product, BriaDx. The Company's BriaDx program is focused on analyzing samples obtained from patients previously treated with BriaVax along with co-analysis of previously manufactured vaccine lots. The Company's analysis methods include various technologies, including gene expression profiling by Illumina microarrays and human leukocyte antigen (HLA) typing by a high-resolution method. The Company is focused on understanding the mechanism of action (MoA) of BriaVax.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Medical Specialties Therapy Oncology Immunology Antigen Immunotherapy Cancer Immunotherapy Biotechnology Companies Breast Cancer Vaccine

Is BCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.0
52 Week Low 0.64
Average Volume 64,195
200-Day Moving Average 2.365
50-Day Moving Average 1.026
20-Day Moving Average 0.989
10-Day Moving Average 0.874
Average True Range 0.096
RSI (14) 40.83
ADX 19.73
+DI 22.367
-DI 29.701
Chandelier Exit (Long, 3 ATRs) 1.092
Chandelier Exit (Short, 3 ATRs) 1.068
Upper Bollinger Bands 1.261
Lower Bollinger Band 0.716
Percent B (%b) 0.25
BandWidth 55.094
MACD Line -0.083
MACD Signal Line -0.061
MACD Histogram -0.0221
Fundamentals Value
Market Cap 656.17 Thousand
Num Shares 772 Thousand
EPS -0.04
Price-to-Earnings (P/E) Ratio -22.37
Price-to-Sales 0.00
Price-to-Book 10.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.955
Resistance 3 (R3) 0.947 0.903 0.938
Resistance 2 (R2) 0.903 0.877 0.908 0.932
Resistance 1 (R1) 0.877 0.860 0.890 0.885 0.926
Pivot Point 0.833 0.833 0.840 0.838 0.833
Support 1 (S1) 0.807 0.807 0.820 0.815 0.774
Support 2 (S2) 0.763 0.790 0.768 0.768
Support 3 (S3) 0.737 0.763 0.763
Support 4 (S4) 0.745